Postoperative continuation of antidepressant therapy is associated with reduced short-term weight loss following Roux-en-Y gastric bypass surgery.
Philip PlaekeFilip Van Den EedeBen GysAnthony BeunisMartin RuppertJoris De ManBenedicte De WinterGuy HubensPublished in: Langenbeck's archives of surgery (2019)
Treatment with antidepressants was associated with reduced weight loss after gastric bypass surgery, but only if treatment was continued for at least 1 year postoperatively. Mainly tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors were responsible for this reduction in weight loss.
Keyphrases
- weight loss
- roux en y gastric bypass
- gastric bypass
- bariatric surgery
- obese patients
- major depressive disorder
- minimally invasive
- coronary artery bypass
- type diabetes
- weight gain
- glycemic control
- stem cells
- body mass index
- metabolic syndrome
- adipose tissue
- combination therapy
- atrial fibrillation
- mesenchymal stem cells
- bipolar disorder